Interestingly, these cells not only exhibited strong anti-tumor reactivity and potent proliferative capacity of αβ T cells, leading to tumor eradication in leukemic PDX models, they also retained both CD4+ and CD8+ effector cell functions (94). This evidence concerns the gene CD8A and neoplasm.